Explore more publications!
Michigan Technology Journal
Got News to Share?

Michigan Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Technology Journal.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on February 27, 2026

Kraft Business Systems to Host Free Cybersecurity Event for Northern Michigan Small Businesses
Feb. 27, 2026

Kraft Business Systems to Host Free Cybersecurity Event for Northern Michigan Small Businesses

Indeterminate EIN Presswire
ITS America Conference & Expo and SwRI Launch Future Leaders Program
Feb. 27, 2026

ITS America Conference & Expo and SwRI Launch Future Leaders Program

Indeterminate EIN Presswire
Sophus Technology to Host Live Webinar Showcasing Next-Generation Quantum Solver Delivering 50–100x Faster Optimization
Feb. 27, 2026

Sophus Technology to Host Live Webinar Showcasing Next-Generation Quantum Solver Delivering 50–100x Faster Optimization

Indeterminate EIN Presswire
IGEL Continues Executive Leadership Expansion with Appointment of Ash Chowdappa as Chief Product & Development Officer
Feb. 27, 2026

IGEL Continues Executive Leadership Expansion with Appointment of Ash Chowdappa as Chief Product & Development Officer

Indeterminate GlobeNewswire
FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
Feb. 27, 2026

FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older

Indeterminate GlobeNewswire
OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.
Feb. 27, 2026

OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.

Indeterminate GlobeNewswire
Ramsey Theory Group CEO Dan Herbatschek Announces Ashutosh Sharma Appointed to Head of Engineering
Feb. 27, 2026

Ramsey Theory Group CEO Dan Herbatschek Announces Ashutosh Sharma Appointed to Head of Engineering

Indeterminate GlobeNewswire
IGEL Continues Executive Leadership Expansion with Appointment of Ash Chowdappa as Chief Product & Development Officer
Feb. 27, 2026

IGEL Continues Executive Leadership Expansion with Appointment of Ash Chowdappa as Chief Product & Development Officer

Indeterminate GlobeNewswire
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
Feb. 27, 2026

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

Indeterminate GlobeNewswire
Microchip Technology to Present at the Raymond James Institutional Investors Conference
Feb. 27, 2026

Microchip Technology to Present at the Raymond James Institutional Investors Conference

Indeterminate GlobeNewswire
Microchip Technology to Present at the Morgan Stanley Technology, Media & Telecom Conference
Feb. 27, 2026

Microchip Technology to Present at the Morgan Stanley Technology, Media & Telecom Conference

Indeterminate GlobeNewswire
PrimeEnergy Resources Corporation Announces Borrowing Base Reaffirmation and Pricing Reduction Under Credit Facility
Feb. 27, 2026

PrimeEnergy Resources Corporation Announces Borrowing Base Reaffirmation and Pricing Reduction Under Credit Facility

Indeterminate GlobeNewswire
Draganfly Announces Closing of US$50.0 Million Registered Direct Offering
Feb. 27, 2026

Draganfly Announces Closing of US$50.0 Million Registered Direct Offering

Indeterminate GlobeNewswire
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
Feb. 27, 2026

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Indeterminate GlobeNewswire
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Feb. 27, 2026

NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update

Indeterminate GlobeNewswire
Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference
Feb. 27, 2026

Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference

Indeterminate GlobeNewswire
Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Ohio
Feb. 27, 2026

Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Ohio

Indeterminate GlobeNewswire
Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Missouri
Feb. 27, 2026

Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Missouri

Indeterminate GlobeNewswire
Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial
Feb. 27, 2026

Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial

Indeterminate GlobeNewswire
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at…
Feb. 27, 2026

Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at…

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions